What does AlloVir, Inc. do?

Jun 22 2025 06:59 PM IST
share
Share Via
AlloVir, Inc. is a late clinical-stage cell therapy company focused on developing allogeneic T cell therapies for viral diseases, with a market cap of approximately $47.88 million and a net profit of -$10 million as of March 2025. The company operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.
Overview:
AlloVir, Inc. is a late clinical-stage cell therapy company engaged in developing allogeneic T cell therapies to treat and prevent viral diseases, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.

Financial Snapshot:
Net Profit: -10 Million (Quarterly Results - Mar 2025)
Market Cap: USD 47.88 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -1.58
Return on Equity: -61.61%
Price to Book: 0.75

Contact Details:
Address: 139 Main Street, Suite 500, Suite 1274, CAMBRIDGE MA: 02142
Tel: 1 617 4332605
Fax: 1 302 6555049
Website: https://www.allovir.com
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is AlloVir, Inc. technically bullish or bearish?
Sep 20 2025 08:02 PM IST
share
Share Via
Is AlloVir, Inc. technically bullish or bearish?
Jun 25 2025 09:01 AM IST
share
Share Via
Who are in the management team of AlloVir, Inc.?
Jun 22 2025 10:41 PM IST
share
Share Via
How big is AlloVir, Inc.?
Jun 22 2025 06:12 PM IST
share
Share Via